相关实验视频

Updated: Jun 11, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

β-arrestin2:在炎症性免疫疾病中是一个新兴的参与者和潜在的治疗点

Ping-Ping Gao¹, Ling Li¹, Ting-Ting Chen¹

¹Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, China.

Acta pharmacologica Sinica

|September 30, 2024

概括

β-arrestin2在免疫反应和炎症性疾病中至关重要. 准β-arrestin2为治疗各种免疫相关炎症状况提供了一个有前途的治疗策略.

科学领域:

分子生物学分子生物学
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

β-arrestin2 (β-arrestin2) 是一个关键蛋白调节G蛋白合受体 (GPCRs) 信号传递的关键蛋白.
它在细胞质,血和细胞核中起作用,影响细胞过程.
新出现的证据凸显了其在各种信号通路中的非GPCR作用.

研究的目的:

审查β-arrestin2在炎症性免疫反应中的多方面的作用.
探索β-arrestin2在各种炎症性免疫疾病中的病理意义.
评估调节β-arrestin2在疾病治疗中的治疗潜力.

主要方法:

关于β-arrestin2功能和参与疾病的研究的文献综述.
分析β-arrestin2在GPCR脱敏和支架中的双重作用.
检查β-arrestin2对非GPCR通路 (NF-κB,MAPK,TGF-β) 的影响.

主要成果:

β-arrestin2调解了GPCR的脱敏化和内部化.
它作为激酶激活和信号通路调节的支架.
β-arrestin2对于免疫细胞的透,炎症因子的释放和增殖至关重要.

结论:

β-arrestin2是炎症性免疫疾病病原体的组成部分.
它的参与涵盖了诸如炎症性肠病,败血症,喘,类风湿性关节炎,纤维化和瘤等疾病.
向β-arrestin2代表了炎症性免疫疾病的有希望的治疗途径.

关键词:

细胞信号传递是细胞的信号传递.药物目标是药物目标.免疫细胞免疫细胞炎症性免疫疾病是一种炎症性免疫疾病.这是一种炎症性免疫反应.这是一种β-arrestin2的组合.

更多相关视频

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...